oscar health inc - OSCR
OSCR
Close Chg Chg %
11.73 0.19 1.58%
Closed Market
11.91
+0.19 (1.58%)
Volume: 4.37M
Last Updated:
Apr 2, 2026, 3:59 PM EDT
Company Overview: oscar health inc - OSCR
OSCR Key Data
| Open $11.29 | Day Range 11.29 - 11.94 |
| 52 Week Range 10.69 - 23.75 | Market Cap $3.49B |
| Shares Outstanding 297.75M | Public Float 242.17M |
| Beta 1.93 | Rev. Per Employee N/A |
| P/E Ratio N/A | EPS -$1.57 |
| Yield 0.00% | Dividend N/A |
| EX-DIVIDEND DATE | SHORT INTEREST N/A |
| AVERAGE VOLUME 6.74M |
OSCR Performance
| 1 Week | 5.30% | ||
| 1 Month | -14.00% | ||
| 3 Months | -18.37% | ||
| 1 Year | -9.77% | ||
| 5 Years | -54.85% |
OSCR Analyst Ratings
- Sell
- Under
- Hold
- Over
- Buy
Number of Ratings
11
Full Ratings ➔
An error occurred while fetching the data.
An error occurred while fetching the data.
Snapshot
| Average Recommendation | HOLD | Average Target Price | 16.00 | |
| Number of Ratings | 11 | Current Quarters Estimate | 0.152 | |
| FY Report Date | 06 / 2026 | Current Year's Estimate | 0.378 | |
| Last Quarter’s Earnings | 1.353 | Median PE on CY Estimate | N/A | |
| Year Ago Earnings | -1.69 | Next Fiscal Year Estimate | 1.114 | |
| Median PE on Next FY Estimate | N/A |
Earnings Per Share
| This Quarter | Next Quarter | This Fiscal | Next Fiscal | |
|---|---|---|---|---|
| # of Estimates | 11 | 11 | 11 | 11 |
| Mean Estimate | 0.15 | -0.06 | 0.38 | 1.11 |
| High Estimates | 0.66 | 0.09 | 1.15 | 1.77 |
| Low Estimate | -0.47 | -0.31 | -0.72 | -0.10 |
| Coefficient of Variance | 241.87 | -197.45 | 170.91 | 52.23 |
Analysts Recommendations
| Current | 1 Month Ago | 3 Months Ago | |
|---|---|---|---|
| BUY | 2 | 2 | 2 |
| OVERWEIGHT | 1 | 1 | 0 |
| HOLD | 5 | 5 | 6 |
| UNDERWEIGHT | 1 | 1 | 1 |
| SELL | 2 | 2 | 2 |
| MEAN | Hold | Hold | Hold |
SEC Filings for Oscar Health Inc - OSCR
| Filing Date | Type | Category | Amended |
|---|---|---|---|
| No results | |||
Insider Actions for Oscar Health Inc - OSCR
| Date | Name | Shares | Transaction | Value |
|---|---|---|---|---|
| Apr 15, 2025 | Jeffery H. Boyd Director | 57,207 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Apr 15, 2025 | David Plouffe Director | 1,734 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Apr 15, 2025 | William J. Gassen Director | 1,530 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Apr 8, 2025 | Mark T. Bertolini Chief Executive Officer; Director | 2,866,666 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Apr 8, 2025 | Mark T. Bertolini Chief Executive Officer; Director | N/A | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |